Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran …
Background Stroke is the most serious clinical consequence of atrial fibrillation, which is the
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis
SA Mitchell, TA Simon, S Raza… - Clinical and applied …, 2013 - journals.sagepub.com
The novel oral anticoagulants (NOACs) apixaban, dabigatran, and rivaroxaban have been
recently indicated for stroke prevention in patients with atrial fibrillation (AF). Due to a lack of …
recently indicated for stroke prevention in patients with atrial fibrillation (AF). Due to a lack of …
Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention
AJ Camm, KAA Fox, E Peterson - Ep Europace, 2018 - academic.oup.com
The aim of this review is to provide context for meta-analyses interpreting data from phase III
stroke prevention studies of non-vitamin K antagonist oral anticoagulants (NOACs) in …
stroke prevention studies of non-vitamin K antagonist oral anticoagulants (NOACs) in …
Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis
J Zhang, X Wang, X Liu, TB Larsen, DM Witt… - European Journal of …, 2021 - Springer
Purpose: To systematically review available evidence of indirect comparisons from RCTs
and direct comparisons from observational studies regarding the comparative effectiveness …
and direct comparisons from observational studies regarding the comparative effectiveness …
Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic …
G Ntaios, V Papavasileiou, K Makaritsis, K Vemmos… - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Evidence from the real-world setting complements evidence
coming from randomized controlled trials. We aimed to summarize all available evidence …
coming from randomized controlled trials. We aimed to summarize all available evidence …
Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data
Z Xue, Y Zhou, C Wu, J Lin, X Liu, W Zhu - Heart Failure Reviews, 2020 - Springer
The role of non-vitamin K antagonist oral anticoagulants (NOACs) in stroke prevention
remains unclear in Asian patients with atrial fibrillation (AF). Therefore, we performed a meta …
remains unclear in Asian patients with atrial fibrillation (AF). Therefore, we performed a meta …
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular …
CI Coleman, JB Briere, L Fauchier, P Levy… - Journal of market …, 2019 - mdpi.com
Introduction: Numerous real-world studies have compared non-vitamin K antagonist oral
anticoagulants (NOACs) with vitamin K antagonists (VKAs) in patients with non-valvular …
anticoagulants (NOACs) with vitamin K antagonists (VKAs) in patients with non-valvular …
Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis
S Deitelzweig, E Bergrath, M di Fusco, A Kang… - Future …, 2022 - Future Medicine
Aim: To compare real-world effectiveness/safety of non-vitamin K antagonist oral
anticoagulants and vitamin K antagonists among patients with non-valvular atrial fibrillation …
anticoagulants and vitamin K antagonists among patients with non-valvular atrial fibrillation …
Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients
Background and Purpose: Several observational studies have compared the effect of the
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …